Vertex Pharmaceuticals ( VRTX )
Name Type
Costs And Expenses: Cost Of Product Revenues Annual
Costs And Expenses: Intangible Asset Impairment Charges Annual
Costs And Expenses: Research And Development Expenses Annual
Costs And Expenses: Restructuring Expenses Annual
Costs And Expenses: Royalty Expenses Annual
Costs And Expenses: Sales General And Administrative Expenses Annual
Costs And Expenses: Total Costs And Expenses Annual
Earnings Per Share: Basic Annual
Earnings Per Share: Diluted Annual
Income From Operations Annual
Interest Expense Net Annual
Loss Attributable To Noncontrolling Interest Annual
Loss attributable to noncontrolling interest Annual
Loss From Continuing Operations Before Provision For Income Taxes Annual
Loss From Discontinued Operations Annual
Loss From Discontinued Operations Net Of Tax Benefit Of $0 $0 And $0 Respectively Annual
Net Income Annual
Net Loss Attributable To Vertex Annual
Net Loss From Continuing Operations: Basic Annual
Net Loss From Continuing Operations: Diluted Annual
Net Loss From Discontinued Operations: Basic Annual
Net Loss From Discontinued Operations: Diluted Annual
Other Income Net Annual
Provision For Income Taxes Annual
Revenues: Collaborative Revenues Annual
Revenues: Product Revenues Net Annual
Revenues: Royalty Revenues Annual
Revenues: Total Revenues Annual
Shares Used In Per Share Calculations: Basic Annual
Shares Used In Per Share Calculations: Diluted Annual